Showing results (1-10 of 468) with videos related to
Sort By:
Pageof 47
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|April 13, 2018
CHAPTER 11 How to manage and communicate with patients about HPV?Suzanne M Garland, Michael A QuinnThe Medical Journal of Australia|February 19, 2008
Human papillomavirus vaccination for the prevention of cervical neoplasia: is it appropriate to vaccinate women older than 26?S Rachel Skinner, Suzanne M Garland, Margaret A Stanley, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 28, 2014
Comparison of the Roche Cobas(®) 4800 HPV assay to Digene Hybrid Capture 2, Roche Linear Array and Roche Amplicor for Detection of High-Risk Human Papillomavirus Genotypes in Women undergoing treatment for cervical dysplasiaSamuel Phillips, Suzanne M Garland, Jeffery H Tan, et al.Journal of Clinical Microbiology|May 15, 2007
Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear resultsMatthew P Stevens, Suzanne M Garland, Elice Rudland, et al.Journal of Medical Virology|May 29, 2009
HPV genotype prevalence in women with abnormal pap smears in Melbourne, AustraliaMatthew P Stevens, Suzanne M Garland, Jeffrey H Tan, et al.Pathology|May 5, 2015
Evaluation of p16INK4a immunostaining for the detection of high-grade changes in cervical cytologySepehr N Tabrizi, Sarah E Tan, Christina von Knebel Doeberitz, et al.Pathology|July 12, 2002
Human papillomavirus update with a particular focus on cervical diseaseSuzanne M GarlandGynecologic Oncology|February 9, 2010
Prevention strategies against human papillomavirus in malesSuzanne M GarlandThe Indian Journal of Medical Research|November 11, 2009
Can cervical cancer be eradicated by prophylactic HPV vaccination? Challenges to vaccine implementationSuzanne M GarlandClinical Therapeutics|January 15, 2014
The Australian experience with the human papillomavirus vaccineSuzanne M GarlandPageof 47